Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2026-01-05 @ 5:36 PM
Study NCT ID:
NCT00829166
Status:
COMPLETED
Last Update Posted:
2016-10-31
First Post:
2009-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2012-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-22
First Submit QC Date:
None
Study First Post Date:
2009-01-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-02-22
Results First Submit QC Date:
None
Results First Post Date:
2013-04-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-10
Last Update Post Date:
2016-10-31
Last Update Post Date Type:
ESTIMATED